Literature DB >> 16670550

The definition and treatment of pediatric subtrochanteric femur fractures with titanium elastic nails.

Mathew William Pombo1, Jeffrey S Shilt.   

Abstract

PURPOSE: Titanium elastic nailing (TEN) has become more common in the treatment of pediatric femur fractures in many European centers and in North America over the past several years. Prior studies have shown that the use of TEN for midshaft femur fractures results in excellent outcomes with an earlier return to activity, earlier mobilization, and a shortened hospital stay. However, subtrochanteric femur fractures continue to remain a difficult subset of fractures to care for, with loss of reduction and nonunion being significant complications. Studies have differed regarding the definition of pediatric subtrochanteric femur fractures. The purpose of this study is to establish a reproducible method of defining pediatric subtrochanteric fractures and then apply that definition in a retrospective review of 13 patients who sustained subtrochanteric femur fractures treated with TEN at North Carolina Baptist Hospital using a modified technique that allows for improved fracture stability.
METHODS: Charts and radiographs were retrospectively reviewed for all pediatric patients sustaining subtrochanteric femur fractures treated with TEN from the period of 2000 to 2004 at Wake Forest University. The TEN outcome measures scale was applied to determine their results.
RESULTS: TEN allowed rapid mobilization with excellent or satisfactory clinical and radiographic results in all patients.
CONCLUSIONS: Results suggest that the use of TEN for subtrochanteric femur fractures is a safe and effective method of fixation that benefits patients through early mobilization, shorter hospital stays, and fewer complications. SIGNIFICANCE: By applying the definition of subtrochanteric femur fractures described by the authors, results of future studies can be objectively compared and classified. TEN is a safe and effective alternative for treating most pediatric subtrochanteric fractures by decreasing the morbidity that occurs with other treatment modalities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670550     DOI: 10.1097/01.bpo.0000203005.50906.41

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  6 in total

1.  Short hospitalization period with elastic stable intramedullary nails in the treatment of femoral shaft fractures in school children.

Authors:  Fabiano Prata Nascimento; Cláudio Santili; Miguel Akkari; Gilberto Waisberg; Susana Dos Reis Braga; Patrícia Maria Moraes de Barros Fucs
Journal:  J Child Orthop       Date:  2010-01-09       Impact factor: 1.548

2.  Adult proximal humerus locking plate for fixation of paediatric subtrochanteric fractures.

Authors:  P Gogna; M Mohindra; S Verma; A Thora; A Tiwari; R Singla
Journal:  Musculoskelet Surg       Date:  2014-01-09

3.  Extra-articular proximal femur fractures in children and adolescents treated by elastic stable intramedullary nailing.

Authors:  Flavia Alberghina; Antonio Andreacchio; Mattia Cravino; Matteo Paonessa; Federico Canavese
Journal:  Int Orthop       Date:  2019-07-27       Impact factor: 3.075

4.  Elastic nailing for pediatric subtrochanteric and supracondylar femur fractures.

Authors:  Shital N Parikh; Senthil T Nathan; Michael J Priola; Emily A Eismann
Journal:  Clin Orthop Relat Res       Date:  2014-09       Impact factor: 4.176

5.  Titanium elastic nailing versus locking compression plating in school-aged pediatric subtrochanteric femur fractures.

Authors:  Yunlan Xu; Jingxia Bian; Kaiying Shen; Bin Xue
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

6.  Operative choice for subtrochanteric femoral fracture in school-aged children: Triple elastic stable intramedullary nail versus locking plate.

Authors:  Pan Hong; Xiaolong Zhao; Renhao Ze; Saroj Rai; Ruikang Liu; Jin Li; Xin Tang
Journal:  Front Pediatr       Date:  2022-07-26       Impact factor: 3.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.